Coronary Guidewires - Medical Devices Pipeline Assessment, 2017

Published : Jun-2017

No. of Pages : 100

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Coronary Guidewires Overview 7
3 Products under Development 8
3.1 Coronary Guidewires - Pipeline Products by Stage of Development 8
3.2 Coronary Guidewires - Pipeline Products by Territory 9
3.3 Coronary Guidewires - Pipeline Products by Regulatory Path 10
3.4 Coronary Guidewires - Pipeline Products by Estimated Approval Date 11
4 Coronary Guidewires - Pipeline Products under Development by Companies 12
4.1 Coronary Guidewires Companies - Pipeline Products by Stage of Development 12
4.2 Coronary Guidewires - Pipeline Products by Stage of Development 13
5 Coronary Guidewires Companies and Product Overview 14
5.1 Bioscan Technologies Inc. Company Overview 14
5.1.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Blueacre Technology Limited Company Overview 15
5.2.1 Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Boston Scientific Corp Company Overview 16
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 CardioSert Ltd. Company Overview 17
5.4.1 CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 ENDOMATERIALS Company Overview 18
5.5.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Georgia Institute of Technology Company Overview 19
5.6.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Guided Interventions, LLC Company Overview 20
5.7.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 JRjr33, Inc. Company Overview 21
5.8.1 JRjr33, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 MaRVis Technologies GmbH Company Overview 23
5.9.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
5.10 MicroPort Scientific Corp Company Overview 25
5.10.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25
5.11 Occlutech International AB Company Overview 26
5.11.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 26
5.12 OVALUM Ltd Company Overview 27
5.12.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
5.13 St. Jude Medical LLC Company Overview 28
5.13.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.14 Terumo Corp Company Overview 29
5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.15 The Cleveland Clinic Foundation Company Overview 30
5.15.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 30
5.16 University of Illinois at Chicago Company Overview 31
5.16.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
5.17 Vasostar Ltd. Company Overview 32
5.17.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
6 Coronary Guidewires- Recent Developments 33
6.1 May 26, 2017: Merit Medical Announces Appointment of New Director 33
6.2 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 33
6.3 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 36
6.4 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 37
6.5 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 38
6.6 Apr 19, 2017: Opsens Reports Q2 2017 Results - Quarterly Consolidated Revenues Up 75% to $4.8 Million 41
6.7 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 42
6.8 Mar 31, 2017: B. Braun continues its sales and earnings growth 42
6.9 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 44
6.10 Mar 30, 2017: MPSC Announces 2016 Annual Results 45
6.11 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 47
6.12 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 47
6.13 Feb 22, 2017: Change in the B. Braun Management Board 48
6.14 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 48
6.15 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 51
6.16 Feb 09, 2017: Terumo Announces Change of Executive Officers 52
6.17 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 53
6.18 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 54
6.19 Jan 31, 2017: Terumo Opens a Branch in Yangon 55
6.20 Jan 26, 2017: Opsens Reports Q1 2017 Results - Focused Execution Leads to Record Quarterly Revenues 56
6.21 Jan 12, 2017: Anteo Diagnostics Strengthening its Intellectual Property Position in Medical Device Arena 57
6.22 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 57
6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 59
6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 59
6.25 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 62
6.26 Nov 16, 2016: Opsens Reports Results for 2016-Record Total Revenues Driven by Tenfold Increase in FFR Sales 63
6.27 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 64
6.28 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 65
6.29 Nov 03, 2016: DSM Q3 2016 Results 65
6.30 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 68
6.31 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 69
6.32 Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference 70
6.33 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 71
6.34 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 74
6.35 Oct 12, 2016: Hydromer Announces Entering Into 2 Coating Service Agreements Leveraging Its Medical Device Subsidiary, Biosearch Medical Products 75
6.36 Oct 10, 2016: St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies 76
6.37 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 77
6.38 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 78
6.39 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 79
6.40 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 80
6.41 Aug 30, 2016: MPSC Announces 2016 Interim Results 80
6.42 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 82
6.43 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 85
6.44 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 86
6.45 Jul 26, 2016: Merit Medical Announces Appointment of New Director 87
6.46 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 88
6.47 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 88
6.48 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 91
6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 92
6.50 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 93
6.51 Jul 05, 2016: Opsens Announces Fiscal 2016 Third Quarter Results - Sales Of $2,125,000, Up 156% Year-Over-Year 94
6.52 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 95
6.53 Jun 22, 2016: Opsens receives Health Canada approval for the sale of OptoWire II 96
7 Appendix 97
7.1 Methodology 97
7.2 About GlobalData 100
7.3 Contact Us 100
7.4 Disclaimer 100

1.1 List of Tables
Table 1: Coronary Guidewires - Pipeline Products by Stage of Development 8
Table 2: Coronary Guidewires - Pipeline Products by Territory 9
Table 3: Coronary Guidewires - Pipeline Products by Regulatory Path 10
Table 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date 11
Table 5: Coronary Guidewires Companies - Pipeline Products by Stage of Development 12
Table 6: Coronary Guidewires - Pipeline Products by Stage of Development 13
Table 7: Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 8: Lightwire - Product Status 14
Table 9: Lightwire - Product Description 14
Table 10: Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 15
Table 11: Next Generation Guide Wire - Product Status 15
Table 12: Next Generation Guide Wire - Product Description 15
Table 13: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
Table 14: Crossing Wire - Product Status 16
Table 15: Crossing Wire - Product Description 16
Table 16: CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 17: Versatile Guidewire - Product Status 17
Table 18: Versatile Guidewire - Product Description 17
Table 19: ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 18
Table 20: Multimodal Sensing Guidewire - Product Status 18
Table 21: Multimodal Sensing Guidewire - Product Description 18
Table 22: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19
Table 23: Intravascular Ultrasound Imaging Guidewire - Product Status 19
Table 24: Intravascular Ultrasound Imaging Guidewire - Product Description 19
Table 25: Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 26: Pressure Sensing Coronary Artery Guide Wire - Product Status 20
Table 27: Pressure Sensing Coronary Artery Guide Wire - Product Description 20
Table 28: JRjr33, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 29: Maneuverable Coiled Guidewire - Product Status 21
Table 30: Maneuverable Coiled Guidewire - Product Description 21
Table 31: Steerable Guidewire - Product Status 22
Table 32: Steerable Guidewire - Product Description 22
Table 33: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
Table 34: MaRVis 0.014" Micro Guidewire - Product Status 23
Table 35: MaRVis 0.014" Micro Guidewire - Product Description 23
Table 36: MaRVis 0.035" Standard And Stiff Guidewire - Product Status 24
Table 37: MaRVis 0.035" Standard And Stiff Guidewire - Product Description 24
Table 38: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25
Table 39: Micro-Guide Wire - Product Status 25
Table 40: Micro-Guide Wire - Product Description 25
Table 41: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 26
Table 42: Occlutech Stiff Guide Wire - Product Status 26
Table 43: Occlutech Stiff Guide Wire - Product Description 26
Table 44: OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
Table 45: OctoBooster Extension Guidewire - Product Status 27
Table 46: OctoBooster Extension Guidewire - Product Description 27
Table 47: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
Table 48: Sensor Enabled - Quadra Excel Guidewire - Product Status 28
Table 49: Sensor Enabled - Quadra Excel Guidewire - Product Description 28
Table 50: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 51: Wrist Artery Guidewire - Product Status 29
Table 52: Wrist Artery Guidewire - Product Description 29
Table 53: The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 30
Table 54: CTO Guidewire - Product Status 30
Table 55: CTO Guidewire - Product Description 30
Table 56: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
Table 57: CTO Wire - Product Status 31
Table 58: CTO Wire - Product Description 31
Table 59: Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 60: Vibrational Guidewire System - Product Status 32
Table 61: Vibrational Guidewire System - Product Description 32
Table 62: Glossary 99

1.2 List of Figures
Figure 1: Coronary Guidewires - Pipeline Products by Stage of Development 8
Figure 2: Coronary Guidewires - Pipeline Products by Territory 9
Figure 3: Coronary Guidewires - Pipeline Products by Regulatory Path 10
Figure 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date 11

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Coronary Guidewires - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027